{"entity":{"type":"insider","cik":"0001312622","url":"/insider/0001312622","json_url":"/insider/0001312622.json","name":"Foster-Cheek Kaye I","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":17,"first":"2009-12-11","last":"2024-03-11","span_basis":"filed_date"},"name_variants":[{"name":"Foster-Cheek Kaye I","source":"filing","n_filings":17,"first_seen":"2009-12-11","last_seen":"2024-03-11"}],"transactions":[{"id":2216634,"accession":"0001439222-24-000061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-24-000061","line_url":"/filing/0001439222-24-000061#line-1","is_derivative":false,"issuer_cik":"0001312622","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001312622","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1285.0,"shares_display":"1,285","price_per_share":31.62,"price_display":"31.62","price_state":"stated","total_value":40631.7,"total_display":"40,631.70","total_whole":"40,632","shares_owned_after":5524.0,"shares_owned_after_display":"5,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-11","scope":"insider"},{"id":2185071,"accession":"0001439222-24-000058","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000058","line_url":"/filing/0001439222-24-000058#line-2","is_derivative":false,"issuer_cik":"0001312622","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001312622","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4415.0,"shares_display":"4,415","price_per_share":31.99,"price_display":"31.99","price_state":"stated","total_value":141235.85,"total_display":"141,235.85","total_whole":"141,236","shares_owned_after":6809.0,"shares_owned_after_display":"6,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-06","filed_date":"2024-03-07","scope":"insider"},{"id":2185068,"accession":"0001439222-24-000058","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-24-000058","line_url":"/filing/0001439222-24-000058#line-1","is_derivative":false,"issuer_cik":"0001312622","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001312622","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":32.21,"price_display":"32.21","price_state":"stated","total_value":9663.0,"total_display":"9,663.00","total_whole":"9,663","shares_owned_after":11224.0,"shares_owned_after_display":"11,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-07","scope":"insider"},{"id":7931324,"accession":"0001439222-23-000125","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-23-000125","line_url":"/filing/0001439222-23-000125#line-2","is_derivative":false,"issuer_cik":"0001312622","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001312622","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":25.9555,"price_display":"25.96","price_state":"stated","total_value":648887.5,"total_display":"648,887.50","total_whole":"648,888","shares_owned_after":11524.0,"shares_owned_after_display":"11,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-09","filed_date":"2023-08-11","scope":"insider"},{"id":6017216,"accession":"0001209191-18-038277","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-038277","line_url":"/filing/0001209191-18-038277","is_derivative":false,"issuer_cik":"0001312622","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001312622","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":93.54736888888888,"price_display":"93.55","price_state":"stated","total_value":841926.32,"total_display":"841,926.32","total_whole":"841,926","shares_owned_after":3039.0,"shares_owned_after_display":"3,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-14","filed_date":"2018-06-18","scope":"insider","n_lines":3},{"id":6290516,"accession":"0001209191-18-021060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-021060","line_url":"/filing/0001209191-18-021060#line-2","is_derivative":false,"issuer_cik":"0001312622","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001312622","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6800.0,"shares_display":"6,800","price_per_share":81.97,"price_display":"81.97","price_state":"stated","total_value":557396.0,"total_display":"557,396.00","total_whole":"557,396","shares_owned_after":2200.0,"shares_owned_after_display":"2,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-19","filed_date":"2018-03-21","scope":"insider"},{"id":4383411,"accession":"0001179110-13-012864","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-13-012864","line_url":"/filing/0001179110-13-012864","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Officer (SVP, Global Human Resources)","role_mark":"O","role_mark_label":"Officer (SVP, Global Human Resources)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Human Resources","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8878.0,"shares_display":"8,878","price_per_share":132.81049231808967,"price_display":"132.81","price_state":"stated","total_value":1179091.5508,"total_display":"1,179,091.55","total_whole":"1,179,092","shares_owned_after":27566.0,"shares_owned_after_display":"27,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-06","filed_date":"2013-08-08","scope":"insider","n_lines":2},{"id":4971867,"accession":"0001179110-13-008033","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-13-008033","line_url":"/filing/0001179110-13-008033","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Officer (SVP, Global Human Resources)","role_mark":"O","role_mark_label":"Officer (SVP, Global Human Resources)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Human Resources","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8877.0,"shares_display":"8,877","price_per_share":89.83843978821675,"price_display":"89.84","price_state":"stated","total_value":797495.83,"total_display":"797,495.83","total_whole":"797,496","shares_owned_after":27566.0,"shares_owned_after_display":"27,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-07","filed_date":"2013-05-08","scope":"insider","n_lines":2},{"id":4587020,"accession":"0001179110-13-006441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-006441","line_url":"/filing/0001179110-13-006441#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Officer (SVP, Global Human Resources)","role_mark":"O","role_mark_label":"Officer (SVP, Global Human Resources)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Human Resources","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1767.0,"shares_display":"1,767","price_per_share":89.62,"price_display":"89.62","price_state":"stated","total_value":158358.54,"total_display":"158,358.54","total_whole":"158,359","shares_owned_after":27066.0,"shares_owned_after_display":"27,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-02","filed_date":"2013-04-03","scope":"insider"},{"id":4587014,"accession":"0001179110-13-006441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-006441","line_url":"/filing/0001179110-13-006441#line-1","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Officer (SVP, Global Human Resources)","role_mark":"O","role_mark_label":"Officer (SVP, Global Human Resources)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Human Resources","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2066.0,"shares_display":"2,066","price_per_share":86.15,"price_display":"86.15","price_state":"stated","total_value":177985.9,"total_display":"177,985.90","total_whole":"177,986","shares_owned_after":28833.0,"shares_owned_after_display":"28,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-01","filed_date":"2013-04-03","scope":"insider"},{"id":4382334,"accession":"0001179110-13-003191","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-13-003191","line_url":"/filing/0001179110-13-003191#line-4","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Officer (SVP, Global Human Resources)","role_mark":"O","role_mark_label":"Officer (SVP, Global Human Resources)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Human Resources","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16164.0,"shares_display":"16,164","price_per_share":74.96,"price_display":"74.96","price_state":"stated","total_value":1211653.44,"total_display":"1,211,653.44","total_whole":"1,211,653","shares_owned_after":25499.0,"shares_owned_after_display":"25,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-15","filed_date":"2013-02-20","scope":"insider"},{"id":2297970,"accession":"0001179110-12-015846","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-12-015846","line_url":"/filing/0001179110-12-015846#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Officer (SVP, Global Human Resources)","role_mark":"O","role_mark_label":"Officer (SVP, Global Human Resources)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Human Resources","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7112.0,"shares_display":"7,112","price_per_share":75.9,"price_display":"75.90","price_state":"stated","total_value":539800.8,"total_display":"539,800.80","total_whole":"539,801","shares_owned_after":25499.0,"shares_owned_after_display":"25,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-06","filed_date":"2012-11-08","scope":"insider"},{"id":3046793,"accession":"0001179110-12-014922","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-014922","line_url":"/filing/0001179110-12-014922#line-1","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Officer (SVP, Global Human Resources)","role_mark":"O","role_mark_label":"Officer (SVP, Global Human Resources)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Human Resources","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2015.0,"shares_display":"2,015","price_per_share":85.08,"price_display":"85.08","price_state":"stated","total_value":171436.2,"total_display":"171,436.20","total_whole":"171,436","shares_owned_after":27836.0,"shares_owned_after_display":"27,836","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-02","filed_date":"2012-10-04","scope":"insider"},{"id":2537137,"accession":"0001209191-12-041041","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-12-041041","line_url":"/filing/0001209191-12-041041","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Officer (SVP, Global Human Resources)","role_mark":"O","role_mark_label":"Officer (SVP, Global Human Resources)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Human Resources","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29514.0,"shares_display":"29,514","price_per_share":70.48917090194485,"price_display":"70.49","price_state":"stated","total_value":2080417.39,"total_display":"2,080,417.39","total_whole":"2,080,417","shares_owned_after":43574.0,"shares_owned_after_display":"43,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-06","filed_date":"2012-08-08","scope":"insider","n_lines":3},{"id":2821034,"accession":"0001209191-12-039431","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-039431","line_url":"/filing/0001209191-12-039431#line-1","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Officer (SVP, Global Human Resources)","role_mark":"O","role_mark_label":"Officer (SVP, Global Human Resources)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Human Resources","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2335.0,"shares_display":"2,335","price_per_share":73.9717,"price_display":"73.97","price_state":"stated","total_value":172723.9195,"total_display":"172,723.92","total_whole":"172,724","shares_owned_after":43574.0,"shares_owned_after_display":"43,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-25","filed_date":"2012-07-27","scope":"insider"},{"id":8961270,"accession":"0001209191-11-060164","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-060164","line_url":"/filing/0001209191-11-060164#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Officer (SVP, Global Human Resources)","role_mark":"O","role_mark_label":"Officer (SVP, Global Human Resources)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Human Resources","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29500.0,"shares_display":"29,500","price_per_share":43.556,"price_display":"43.56","price_state":"stated","total_value":1284902.0,"total_display":"1,284,902.00","total_whole":"1,284,902","shares_owned_after":27914.0,"shares_owned_after_display":"27,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-05","filed_date":"2011-12-07","scope":"insider"},{"id":8997970,"accession":"0001209191-11-050303","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-050303","line_url":"/filing/0001209191-11-050303#line-1","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Officer (SVP, Global Human Resources)","role_mark":"O","role_mark_label":"Officer (SVP, Global Human Resources)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Human Resources","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1605.0,"shares_display":"1,605","price_per_share":29.7505,"price_display":"29.75","price_state":"stated","total_value":47749.5525,"total_display":"47,749.55","total_whole":"47,750","shares_owned_after":30914.0,"shares_owned_after_display":"30,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-03","filed_date":"2011-10-04","scope":"insider"},{"id":9133675,"accession":"0001209191-11-049082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-049082","line_url":"/filing/0001209191-11-049082#line-1","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Officer (SVP, Global Human Resources)","role_mark":"O","role_mark_label":"Officer (SVP, Global Human Resources)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Human Resources","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1781.0,"shares_display":"1,781","price_per_share":30.0026,"price_display":"30.00","price_state":"stated","total_value":53434.6306,"total_display":"53,434.63","total_whole":"53,435","shares_owned_after":32519.0,"shares_owned_after_display":"32,519","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-23","filed_date":"2011-09-26","scope":"insider"},{"id":5695039,"accession":"0000200406-09-000142","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000200406-09-000142","line_url":"/filing/0000200406-09-000142#line-5","is_derivative":false,"issuer_cik":"0000200406","issuer_name":"JOHNSON & JOHNSON","issuer_ticker":"JNJ","issuer_name_source":null,"issuer_url":"/issuer/0000200406","owner_cik":"0001312622","owner_name":"Foster-Cheek Kaye I","owner_display_name":"Foster-Cheek Kaye I","owner_url":"/insider/0001312622","role":"Officer (VP, Human Resources)","role_mark":"O","role_mark_label":"Officer (VP, Human Resources)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Human Resources","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":96742.0,"shares_display":"96,742","price_per_share":64.76,"price_display":"64.76","price_state":"stated","total_value":6265011.92,"total_display":"6,265,011.92","total_whole":"6,265,012","shares_owned_after":4583.0,"shares_owned_after_display":"4,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-10","filed_date":"2009-12-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS, INC.","url":"/issuer/0001439222","role":"Director","n_filings":5,"first_seen":"2018-03-21","last_seen":"2024-03-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001012140","name":"ONYX PHARMACEUTICALS INC","url":"/issuer/0001012140","role":"Officer (SVP, Global Human Resources)","n_filings":11,"first_seen":"2011-09-26","last_seen":"2013-08-08"},{"type":"issuer","type_label":"ISSUER","cik":"0000200406","name":"JOHNSON & JOHNSON","url":"/issuer/0000200406","role":"Officer (VP, Human Resources)","n_filings":1,"first_seen":"2009-12-11","last_seen":"2009-12-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001312622","retrieved_at":"2026-08-25T02:13:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}